Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof

VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof

US Patent 8350026 · Granted Jan 8, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosage regimen2025
Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibito2024
Enzymatic encoding methods for efficient synthesis of large libraries2023
Small molecule modulators of IL-172022
Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibito2022
Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodie2022
IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chro2022
Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesteras2022
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Method for the synthesis of a bifunctional complex2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021